Essential hypertension is a complex trait of environmental and genetic contributors. 1 Heritability of hypertension has been estimated to be ~20-60% in the human twin and family studies. 2 The genetic bases of several rare monogenic forms of hypertension which involve several nuclear and mitochondrial genes have been elucidated in humans. 3 Many potential hypertension association genes such as ATP2B1 have been suggested through genome-wide linkage and association studies. [2] [3] [4] [5] In addition, it has been suggested that single-nucleotide polymorphisms (SNPs) in the mitochondrial genome may have potential role in hypertension. 6 However, the vast majority of the monogenic and polygenic genetic factors in hypertension and blood pressure (BP) are still unknown. Accumulating evidence in the literature suggests that hypertension is associated with oxidative stress, endothelial dysfunction, and increased vascular resistance, 7 which leads to a highly significant relationship between mitochondrial dysfunction and hypertension.
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Association Between OPA1 and BP/Hypertension Mfn2) and optic atrophy protein 1 (Opa1) and two mitochondrial fission-regulating proteins, GTPase dynamin-related protein 1 (Drp1) and mitochondrial outer membrane fission 1 protein (Fis1). 9, 10 In addition, many additional regulatory proteins such as RAB32, MICS1, MARCH-V/MITOL, MTP18, GDAP1, DAP3, USP30, and Mff mediating mitochondrial fusion and fission have been identified. 11, 12 Maintenance of the overall shape of mitochondria via control of the equilibrium between fusion and fission is essential for homeostasis in cells. 10 Mitochondrial dynamics is linked with various mitochondrial functions. In particular, mitochondrial dynamics has been reported to play a key role in the control of the spatiotemporal properties of mitochondrial Ca 2+ responses and ROS production. 13, 14 The Ca 2+ coupling between mitochondria and endoplasmic reticulum that are interconnected both physically and physiologically is controlled by mitochondrial morphology. 13 Based on the fact that mitochondrial dysfunction causing alteration in the cellular ROS metabolism and calcium handling is closely related with vascular disease states such as hypertension, 7, [15] [16] [17] it has been suggested that defects in mitochondrial dynamics may be involved in the pathogenesis of hypertension. In addition, it has been suggested that changes in mitochondrial morphology may actually be relevant to cardiovascular diseases. 18, 19 Most recently, MFN2 gene polymorphisms have been reported to be associated with essential hypertension in Chinese population. 20 In this study, we investigated whether genetic variation of the five major mitochondrial-shaping genes was associated with the susceptibility to BP and hypertension in the Korean study cohort.
Methods
Subjects. The subjects of the Korean Association Resource (KARE) study which were used in this study have been described in the previous report. 21 Briefly, a total of 8,842 participants aged from 40 to 69 years were recruited from two community-based epidemiological cohorts, the rural community of Ansung and the urban community of Ansan cities. Both cohort samples were collected in 2001 as part of the Korean Genome Epidemiology Study (KoGES) . To analyze accurate BP traits, 330 subjects who had been treated with drugs such as folk medicine that were likely to influence the BP were excluded, and the remaining 8,512 subjects were finally investigated in this study. The basic characteristics of the study subjects are shown in Table 1 .
For quantitative BP trait analysis, 961 subjects who were undergoing antihypertensive treatment were excluded and remaining 7,551 subjects were investigated. For case-control analysis, normal control subjects (n = 4,452) and case subjects (n = 1,968) were analyzed. Normal controls included subjects who had systolic BP (SBP) <120 mm Hg and diastolic BP (DBP) <80 mm Hg and hypertensive cases included 1,007 subjects who had SBP 
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Association Between OPA1 and BP/Hypertension ≥140 mm Hg and/or DBP ≥90 mm Hg in addition to the above 961 subjects who were using antihypertensive medications, generating a total of 1,968 cases. The subjects with prehypertension status (120 mm Hg <SBP <140 mm Hg, and/or 80 mm Hg <DBP <90 mm Hg) were excluded from the case-control analysis. The basic characteristics of the final subjects used in this study are described in Table 1 . BP measurements were taken three times in the supine position using a mercury sphygmomanometer (Baumanometer; W.A. Baum, Copiague, NY) with an appropriate cuff size by trained nurses, and the average value data was used for this study. Before the first measurement, subjects rested for 5 min, and three measurements were taken at least 30 s apart. This study was approved by the institutional review board committees of the Korean National Institute of Health. Written informed consent was obtained from all the subjects.
Genotyping and SNPs selection. The genotype data were graciously provided by the Center for Genome Science, the Korea National Institute of Health. The detailed genotyping and quality control processes have been described in the previous report. 21 Briefly, most DNA samples were isolated from the peripheral blood of participants and genotyped using the Affymetix Genome-Wide Human SNP array 5.0 (Affymetrix, Santa Clara, CA). The SNPs studied in the five mitochondriashaping genes were selected based on their locations within the gene boundary (20 kb upstream and downstream of the first and last exons, respectively) according to NCBI human genome build 36 (Supplementary Table S1 ). Information about the SNPs analyzed in the five genes encoding the major mitochondria-shaping proteins regulating the mitochondrial fusion and fission machinery; fusion proteins (Mfn1, Mfn2, and Opa1), and fission proteins (Fis1 and Drp1) are shown in Table 2 . The LD blocks of the five genes were generated by the Haploview program using the KARE data of Korean population and LD structure of the OPA1 gene are shown in the representative Supplementary Figure S1 . The total 52 SNPs in the five genes were partitioned into a total eight LD blocks; the MF1, MFN2, and DNM1L genes were partitioned into 1 LD block each, the FIS1 gene was partitioned into two LD blocks, and the OPA1 gene was partitioned into three LD blocks. We performed the quantitative BP trait analysis and hypertension case-control analysis for the 52 SNPs in the five genes in the total KARE study cohort (8,512 subjects) . No significant associations of the SNPs in the all genes tested satisfying the Bonferroni-corrected P value (<0.00625 calculated by 0.05/8 LD blocks) were observed ( Table 3) . However, 14 of the 26 SNPs in the OPA1 gene showed a weak association with SBP (P values: 0.034-0.049) ( Table 3) , suggesting the possibility of an association between the OPA1 gene and BP traits. Since previous studies have reported that heritability of BP increased with age, 22, 23 we examined whether the significance of the association of the SNPs with BP and/or hypertension depends on the subjects' age. The KARE subjects were divided into three subgroups according to age, and the 52 SNPs in the five genes were reanalyzed. The age subgroups for the quantitative BP trait analysis comprised of 3,863, 1,901, and 1,787 subjects in the 40s, 50s, and 60s subgroups, respectively. The age subgroups for the logistic regression analysis comprised of 2,731 controls vs. 486 cases, 1,005 controls vs. 611 cases, and 715 controls vs. 869 cases in the 40s, 50s, and 60s subgroups, respectively. Notably, the reanalysis results revealed an age-dependent association of the SNPs in the OPA1 gene, but no association for the other four genes was observed in any age subgroups ( Table 4 and Supplementary Table S2 ). Total 15 SNPs out of 26 SNPs genotyped in the OPA1 gene showed a significant association with SBP, DBP, and/or hypertension only in the 60s age subgroup; 15 SNPs showed a significant association with SBP, 11 SNPs showed a significant association with DBP, and 9 SNPs showed a significant association with hypertension ( Table 4) . Their association P values remained lower than the Bonferroni-corrected P value threshold (0.00626); SBP: P = 0.00057-0.004, DBP: P = 0.00025-0.0058, hypertension: P = 0.0014-0.0053. The SNPs rs10804955, rs7646250, and rs6764269 showed the most significant association with SBP, DBP, and hypertension, respectively. Noticeably, nine SNPs were consistently associated with all the three traits; SBP, DBP, and hypertension. In all the nine SNPs, their β values in SBP and DBP were in the same direction and showed consistent trends with the odds ratios of hypertension. Among these, eight SNPs except for SNP rs6764269 were distributed in the same LD block (Supplementary Figure S1) . To provide a suitable control group, we excluded the 40s age subgroup in both the control and case groups and analyzed in the 50s, 60s, and the combined 50-60s age subgroups (Supplementary Table S2 ). The results showed a significant association between the genetic variations in OPA1 gene and hypertension in the 60s age subgroup only. This result is consistent with the result obtained using all subjects including 40s age subgroup in the analysis (Table 4) . Consequently, these results suggest that the older-aged subjects with the minor alleles of the nine SNPs in the OPA1 gene may be less susceptible to the development of hypertension.
Furthermore, we performed an association analysis of the SNPs in the OPA1 gene with BP and hypertension in the male and female subgroups of the 60's age subgroup separately (Supplementary Table S3 ). The SNPs in the OPA1 gene were more significantly associated with BP and hypertension in women than men in an age-dependent manner. In addition, the P values of the association analysis between the SNPs in the OPA1 gene and BP traits in the total subjects of the 60's age subgroup were less than those in the women subjects of the 60's age subgroup.
In silico replication in the southern germany study cohort
To explore this association result in other ethnic study cohorts, we performed in silico lookup analysis of the SNPs in the OPA1 gene in the genome-wide association study data from 60s age subgroup of the Kooperative Gesundheitsforschung in der Region Augsburg (KORA) S3 cohort (n = 547; Southern Germany). 24 However, none of the SNPs in the OPA1 gene showed a significant association with BP (data not shown), suggesting that genetic variation of OPA1 might be associated with BP and hypertension in a population-specific manner in the Korean population. associated with several disease conditions including hypertension, hyperlipidemia, and diabetes. 7, 15, 16, 25 It is well known that altered mitochondrial function caused by oxidative stress, a state of excessive ROS activity and increased mitochondrial Ca 2+ accumulation is associated with vascular disease states such as hypertension. 7, [15] [16] [17] Representatively, angiotensin II-mediated mitochondrial oxidative damage is known to contribute to the development of vascular endothelial dysfunction. 26 A significant association of mitochondrial uncoupling proteins such as UCP1 and UCP2 with hypertension has been reported. 7 In addition, the mitochondrial tRNA Ile mutation was demonstrated to cause syndromic metabolic defects including hypertension. 27 Recently, mitochondrial dynamics has attracted attention of many investigators from various scientific fields due to its importance in a myriad of cellular functions determining a cell's life and fate. 10, 18, 28 Abnormalities in mitochondrial dynamics have been suggested to be associated with the various human disorders caused by mitochondrial dysfunction. 28 In this study, we investigated whether genetic variations in regulation of the mitochondria-shaping genes, MFN1, MFN2, OPA1, DNM1L, and FIS1, were associated with BP and hypertension traits. At first, after adjustment for multiple testing, no SNP satisfying the Bonferroni-corrected P value (<0.00625) was observed in the total KARE study cohort. However, we identified a weak association between the genetic variation of the OPA1 gene and SBP (P values: 0.034-0.049), which led to a further analysis of the OPA1 gene ( Table 3) . Next, we reanalyzed the results by dividing the subjects into three subgroups according to age and demonstrated an age-dependent association of the SNPs in the OPA1 gene and BP and hypertension in the 60s age subgroup ( Table 4 ). In the 60s age subgroup, 57.7% of the SNPs (15/26 SNPs tested) in the OPA1 gene reached considerable association (P < 0.00625) with BP and/ or hypertension traits. The mean minor allelic effects of the associated SNPs were β = −2.09 for SBP and β = −1.17 for DBP, and the mean resistance to hypertension (odds ratio) was 0.8. These results indicate that the minor alleles of the significant SNPs in the OPA1 gene may have a protective effect against the development of hypertension in the older-aged subjects. The results of the association analysis between the gender subgroups of the 60's age subjects suggested that the SNPs in the OPA1 gene and BP may be associated in both women and men in an age-dependent manner, although gender-skewed association was observed with stronger associations in women (Supplementary Table S3 ). As this association was not replicated in the European KORA cohort, the effect of genetic variants in the OPA1 may be modulated by population's life-style. In order to determine whether the age-dependent association between OPA1 gene and BP/hypertension is specific to the Korean population, further studies in other ethnic populations including Asian populations are necessary.
Previous studies have reported that heritability of BP increased with age 22, 23 and age-associated mitochondrial dysfunction is also well known, 29, 30 suggesting that accumulation of mitochondrial dysfunction that occurs with ageing can directly contribute to the aging phenotypes. In fact, approximately two-thirds of hypertensive individuals are over 60 years of age. 31 Notably, our results revealed that the SNPs in the OPA1 gene were more significantly associated with SBP than DBP in the Korean cohort. This result is consistent with the fact that SBP increases steadily with age. 31 Furthermore, heterozygous mutation of Drosophila OPA1 is linked with multiple organ abnormalities including decreased heart rate and increased heart arrhythmia in an age-dependent manner and shortened lifespan mediated through increased ROS production. 32, 33 These results suggest that genetic variation of the OPA1 gene may be one of the genetic factors contributing to the BP and hypertension traits that are closely related to the subject's age. Mutations in the OPA1 gene have been associated with autosomal dominant optic atrophy resulting in progressive loss of visual acuity, leading to blindness in many cases. 34 An association between genetic variation of the OPA1 gene and normal tension and high tension glaucoma has also been reported. 35 High BP is known to be associated with an increased risk of developing glaucoma. 36 Glaucoma is more common in the people over 60 years of age.
Recently, decreased Opa1 expression was found in heart tissue of the heart failure rats, 37 indicating that altered OPA1 expression is implicated in cardiovascular diseases caused by cell loss. By in silico transcription factor binding site search program in the TRANSFAC database (http://www.cbrc.jp/ research/db/TFSEARCH.html), we found that DNA sequence of the minor allele of the SNP rs7646250 in the OPA1 gene contained FOXA2 transcription factor binding site (85.5 scoring point). 38 Because this SNP is located in intron 2 which is the promoter region of one of the transcriptional splicing variant (ENST00000497189) of OPA1, expression level of the OPA1 variant may be increased by binding of the FOXA2, resulting in an enhancement of mitochondrial fusion. In turn, the increased fusion event may gradually contribute to acquisition of resistance against hypertension.
Among the five mitochondria-shaping genes, MFN2 gene polymorphisms have been previously reported to be associated with essential hypertension in Chinese population, 20 but genetic association of the other four genes with BP or hypertension traits has not yet been reported in the genetic association database (HuGe Navigator: http://hugenavigator.net). Because only 1 SNP in the MFN2 gene was genotyped in our array platform, we could not compare the MFN2 association result with previous result in the Chinese population. 20 Interestingly, both the OPA1 and MFN2 genes are related with the mitochondrial fusion event. The mitochondrial fusion has been reported to play key roles in inhibition of apoptosis, 39 modulation of calcium signaling and ROS production. 13, 14 The fused, elongated mitochondria can possibly absorb Ca 2+ efficiently and thus prevent activation of neuronal nitric oxide synthase and subsequent ROS production in neuronal cells. 40 In fact, Opa1 has been reported to play a role in the control of the spatiotemporal properties of mitochondrial Ca 2+ responses and ROS production. 33, 41 Furthermore, emerging data have suggested that mitochondrial fusion may contribute to cardio-original contributions Association Between OPA1 and BP/Hypertension protective effects. 18 Peroxisome proliferator-activated receptor γ co-activator (PGC)-1α known as the key protein controlling mitochondrial biogenesis is reported to participate in upstream regulation of mitochondrial fusion. 42 Interestingly, the polymorphism of the PPARGC1A gene encoding PGC-1α has been reported to be associated with BP and hypertension, 43 suggesting that the mitochondrial fusion event is closely related with susceptibility to BP and hypertension.
In conclusion, we demonstrated an age-dependent association of the SNPs in the mitochondrial fusion-regulating gene, OPA1, with BP and hypertension in older-aged subjects of the Korean population. Although this association was not replicated in the European population-based cohort, in addition to previous MFN2 association study, our results suggest that altered mitochondrial dynamics, especially involved in the mitochondrial fusion event, may play an important role in the pathogenesis of hypertension. This study may provide insight into the genetic background and the molecular mechanisms involved in the development of hypertension related to mitochondrial dynamics.
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